Related Experiment Videos
Nephron-sparing surgery for renal angiomyolipoma
1Department of Urology, The Cleveland Clinic Foundation, Ohio, USA.
Urology
|October 8, 1998
Summary
Nephron-sparing surgery (NSS) effectively treats renal angiomyolipoma (AML), preserving kidney function and preventing recurrence. This approach is successful even for large tumors, including those in solitary kidneys.
Area of Science:
- Urology
- Oncology
- Nephrology
Background:
- Renal angiomyolipoma (AML) is a benign tumor that can cause complications.
- Treatment is sometimes necessary for symptomatic or large AMLs.
Purpose of the Study:
- To evaluate the efficacy of nephron-sparing surgery (NSS) for renal AML.
- To assess long-term renal function preservation and tumor recurrence after NSS.
Main Methods:
- Retrospective analysis of 27 patients who underwent NSS for renal AML between 1980 and 1997.
- Indications for surgery included symptoms, tumor size ≥4.5 cm, or suspicion of malignancy.
- Patients were categorized into three groups based on renal status: solitary kidney, impaired contralateral kidney, or normal contralateral kidney.
Main Results:
- No operative deaths occurred; all operated kidneys functioned postoperatively without need for dialysis.
- Mean postoperative serum creatinine levels were 1.81 mg/dL (solitary kidney), 0.98 mg/dL (impaired contralateral kidney), and 0.97 mg/dL (normal contralateral kidney).
- No patients experienced AML recurrence or required dialysis during a median follow-up of 39 months (up to 177 months).
Conclusions:
- NSS is a highly successful treatment for renal AML.
- This approach effectively preserves renal function and prevents recurrence, even in complex cases like large tumors or solitary kidneys.